Aktuelle smitsomme sygdomme
Søgeord (%s) valgt. Opdateret for 9 timer siden. 6 emner vises.
1 Bacterial and Fungal Infections in Persons Who Inject Drugs --- Western New York, 2017
Morbidity and Mortality Weekly Report (MMWR), 3.07.2019
Tilføjet 10.11.2019 18:59
During 2014--2017, CDC Emerging Infections Program surveillance data reported that the occurrence of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections associated with injection drug use doubled among persons aged 18--49 years residing in Monroe County in western New York.
2 Changing epidemiology of meticillin-resistant Staphylococcus aureus in 42 hospitals in the Dutch–German border region, 2012 to 2016: results of the search-and-follow-policy
Eurosurveillance: Most Recent Articles, 11.04.2019
Tilføjet 19.04.2019 21:56
Annette Jurke, Inka Daniels-Haardt, Welmoed Silvis, Matthijs S. Berends, Corinna Glasner, Karsten Becker, Robin Köck and Alex W. Friedrich
Introduction
Meticillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections.
Aim
We describe MRSA colonisation/infection and bacteraemia rate trends in Dutch–German border region hospitals (NL–DE-BRH) in 2012–16.
Methods
All 42 NL–DE BRH (8 NL-BRH, 34 DE-BRH) within the cross-border network EurSafety Health-net provided surveillance data (on average ca 620,000 annual hospital admissions, of these 68.0% in Germany). Guidelines defining risk for MRSA colonisation/infection were reviewed. MRSA-related parameters and healthcare utilisation indicators were derived. Medians over the study period were compared between NL- and DE-BRH.
Results
Measures for MRSA cases were similar in both countries, however defining patients at risk for MRSA differed. The rate of nasopharyngeal MRSA screening swabs was 14 times higher in DE-BRH than in NL-BRH (42.3 vs 3.0/100 inpatients; p
3 FDA Clears Faster Diagnostic Test for MRSA
Medscape Infectious Diseases Headlines, 5.12.2019
Tilføjet 06.12.2019 01:34
The cobas vivoDx MRSA test uses a new bacteriophage technology based on bioluminescence to detect MRSA from nasal swab samples in 5 hours or less compared with 24 to 48 hours for conventional cultures.
4 International travel as source of a hospital outbreak with an unusual meticillin-resistant Staphylococcus aureus clonal complex 398, Denmark, 2016
Eurosurveillance: Most Recent Articles, 17.10.2019
Tilføjet 18.10.2019 07:13
Jens Kjølseth Møller, Anders Rhod Larsen, Claus Østergaard, Camilla Holten Møller, Mette Assenholm Kristensen and Jesper Larsen
In May 2016, an unusual outbreak with the Panton-Valentine leukocidin-positive human variant of meticillin-resistant Staphylococcus aureus (MRSA) clonal complex 398 occurred among mothers and infants in the maternity unit of a Danish hospital. MRSA sharing genotypic and phenotypic characteristics was confirmed in 36 cases, including 26 patients, nine household members and a healthcare worker (HCW) who had contact with all the patients. The national MRSA database contained 37 seemingly unlinked MRSA cases whose isolates shared the same genotypic and phenotypic characteristics as the outbreak strain. Whole genome sequencing showed that three of these isolates clustered together with the 36 outbreak isolates, suggesting spread outside the hospital. The HCW and 21 of 37 cases from the national MRSA database had links to south-eastern Asia, where the outbreak strain is endemic. These findings suggest that the HCW acquired the outbreak strain while travelling in south-eastern Asia and then introduced it into the hospital; from there, it spread within the patients’ households and into the community. Screening of travellers returning from countries with high levels of MRSA could be an important intervention to prevent spread of these bacteria into hospitals via patients or HCWs.
5 Vital Signs: Epidemiology and Recent Trends in Methicillin-Resistant and in Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections --- United States
Morbidity and Mortality Weekly Report (MMWR), 7.03.2019
Tilføjet 10.11.2019 18:59
Staphylococcus aureus is a major cause of community- and health care-associated infections, ranging from superficial skin and soft tissue infections (SSTI) to invasive infections, sepsis, and death. Methicillin-resistant S. aureus (MRSA) has long been recognized as a pathogen associated with health care settings; however, in the 1990s, community-associated MRSA infections, causing mostly SSTI, emerged in the United States.
6 Vital Signs: Trends in Staphylococcus aureus Infections in Veterans Affairs Medical Centers - United States, 2005-2017
Morbidity and Mortality Weekly Report (MMWR), 7.03.2019
Tilføjet 10.11.2019 18:59
Staphylococcus aureus is among the most common causes of health care-associated infections and accounts for significant morbidity and mortality. Beginning in 2005, in response to high rates of methicillin-resistant S. aureus (MRSA) infections, the U.S. Department of Veterans Affairs (VA) piloted an MRSA prevention program in 18 VA medical centers (VAMCs).
|